Pancreatic Metastatic Cancer

Pancreatic Metastatic Cancer is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as: Metastatic Pancreatic Cancer · Metastatic Pancreas Cancer · Pancreatic Cancer, Metastatic · Pancreatic Cancer Metastatic · Metastatic Pancreatic Cancers
Classified under: Digestive System Diseases
Endocrine System Diseases
Neoplasms
Indicated drugs: Erlotinib
Leucovorin

Resolves to

Vocabularies

SNOMED CT94459006MedDRA10026314UMLSC0346976

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

261Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Pancreatic Metastatic Cancer share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.